Health Products

ACT-Candesartan 4mg tablets (2018-11-23)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
K49247, K49268, K49269, K50970, K50973, K51008ACT-Candesartan 4mg tablets
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
TabletsDIN 02376520Candesartan Cilexetil 4mg

Introduction

Recalled Products

ACT-Candesartan 4mg tablets

Reason

An impurity out of specification is expected near the expiry date in the affected lots.

Depth of distribution

Wholesalers, Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime